Metagenomic and Targeted Next-Generation Sequencing in Infectious Disease Diagnostics: Current Applications, Challenges, and Future Perspectives
Diagnostics · 25.03.2026 · 16 (7) · 991
DOI: 10.3390/diagnostics16070991 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diagnostics, online erschienen am 25.03.2026. Verfasst von Rong Rong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nosocomial Infection, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 134 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project, Undergraduate teachingquality and teaching reform licensing project SYSU, Undergraduate teaching quality and teaching reform licensing project SYSU.
Abstract (Originalsprache)
Metagenomic and targeted next-generation sequencing (NGS) technologies are rapidly transforming diagnosis and management for infectious diseases. This review comprehensively examines the current applications of metagenomic NGS (mNGS) and targeted NGS (tNGS) in clinical microbiology, highlighting their roles in pathogen detection, antimicrobial resistance profiling, virulence characterization, and outbreak investigation—particularly in complex cases such as pneumonia, critical illness with pulmonary infections, and pediatric acute respiratory illnesses. We discuss the diagnostic performance, advantages, and limitations of these approaches, including challenges related to sensitivity, specificity, standardization, bioinformatic complexity, and cost-effectiveness. Furthermore, we explore emerging opportunities for integrating NGS-based surveillance with public health strategies, such as wastewater epidemiology, to monitor healthcare-associated infections (HAIs) and antimicrobial resistance (AMR) at the population level. Finally, we outline key steps needed to translate these powerful genomic tools from research settings into routine clinical and public health practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nosocomial Infection, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China.
- Zunyi Medical University, Zhuhai Campus, Zhuhai 519000, China.
- Medical Affairs Department, The First Affiliated Hospital, Sun Yat-sen University, No.58 Zhongshan Er Road, Guangzhou 510080, China.
- Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-sen University, No.58 Zhongshan Er Road, Guangzhou 510080, China.
- Department of Laboratory Medicine, People's Hospital of Boluo County, Huizhou 516100, China.
ORCID-Profile: Peisong Chen
Förderung
- Noncommunicable Chronic Diseases-National Science and Technology Major Project
- Undergraduate teachingquality and teaching reform licensing project SYSU
- Undergraduate teaching quality and teaching reform licensing project SYSU
Zitieren
APA
Rong, R., Long, Y., Li, Y., Lin, L., Yang, J., Hu, Z., Liu, D., & Chen, P. (2026). Metagenomic and Targeted Next-Generation Sequencing in Infectious Disease Diagnostics: Current Applications, Challenges, and Future Perspectives. Diagnostics, 16(7), 991. https://doi.org/10.3390/diagnostics16070991
Vancouver
Rong R, Long Y, Li Y, Lin L, Yang J, Hu Z, et al. Metagenomic and Targeted Next-Generation Sequencing in Infectious Disease Diagnostics: Current Applications, Challenges, and Future Perspectives. Diagnostics. 2026;16(7):991. doi:10.3390/diagnostics16070991
BibTeX
@article{Rong2026,
author = {Rong, Rong and Long, Yuni and Li, Yujing and Lin, Lanxi and Yang, Jie and Hu, Ziqi and Liu, Dayue and Chen, Peisong},
title = {Metagenomic and Targeted Next-Generation Sequencing in Infectious Disease Diagnostics: Current Applications, Challenges, and Future Perspectives},
journal = {Diagnostics},
year = {2026},
volume = {16},
number = {7},
pages = {991},
doi = {10.3390/diagnostics16070991}
}
EUVIMED